Market Overview

Hikma Pharma Full-Year Profit Rises 19%


Hikma Pharmaceuticals Plc (OTC: HKMPY) reported a 19% surge in its full-year profit.

Hikma's profit attributable to shareholders climbed to $120.5 million, up from $100.9 million in the year-ago period.

Its revenue rose 21% to $1.11 billion.


Related Articles (HKMPY)

View Comments and Join the Discussion!

Posted-In: profitEarnings News